Omada Health (NASDAQ:OMDA) CFO Steven Cook Sells 1,108 Shares

Key Points

• Omada Health CFO Steven Cook sold 1,108 shares at an average price of $25, generating $27,700; he retained 187,209 shares after the transaction.
• Omada reported quarterly EPS of $0.08, beating estimates by $0.10, while revenue of $87.83 million exceeded the $80.93 million consensus forecast.
• Analyst sentiment remains favorable, with an average “Moderate Buy” rating and a $26.50 average price target; shares recently traded at $24.55.

Omada Health, Inc. (NASDAQ:OMDA - Get Free Report) CFO Steven Cook sold 1,108 shares of Omada Health stock in a transaction dated Thursday, August 27th. The stock was sold at an average price of $25.00, for a total transaction of $27,700.00. Following the sale, the chief financial officer directly owned 187,209 shares of the company's stock, valued at $4,680,225. The trade was a 0.59% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink.

Omada Health Price Performance

Omada Health stock traded up $0.86 during trading hours on Monday, hitting $24.55. The company had a trading volume of 1,404,748 shares, compared to its average volume of 1,250,157. The firm has a 50-day moving average of $22.27 and a 200 day moving average of $17.20. The firm has a market cap of $1.50 billion, a PE ratio of 491.00 and a beta of 1.73. Omada Health, Inc. has a one year low of $10.28 and a one year high of $26.92.

Omada Health (NASDAQ:OMDA - Get Free Report) last issued its quarterly earnings data on Thursday, August 6th. The company reported $0.08 EPS for the quarter, beating the consensus estimate of ($0.02) by $0.10. Omada Health had a net margin of 1.39% and a return on equity of 2.60%. The business had revenue of $87.83 million during the quarter, compared to the consensus estimate of $80.93 million. As a group, research analysts expect that Omada Health, Inc. will post 0.09 earnings per share for the current year.

Analyst Upgrades and Downgrades

A number of equities research analysts recently issued reports on OMDA shares. Barclays boosted their price objective on Omada Health from $20.00 to $25.00 and gave the company an "overweight" rating in a research note on Monday, August 3rd. Morgan Stanley restated an "overweight" rating and issued a $30.00 target price on shares of Omada Health in a research note on Monday, June 22nd. Weiss Ratings raised shares of Omada Health from a "sell (e+)" rating to a "sell (d+)" rating in a research note on Tuesday, August 11th. Evercore reiterated an "outperform" rating and set a $20.00 price target on shares of Omada Health in a research report on Friday, May 8th. Finally, JPMorgan Chase & Co. increased their target price on Omada Health from $26.00 to $30.00 and gave the company an "overweight" rating in a report on Friday, August 14th. Eleven research analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, Omada Health presently has an average rating of "Moderate Buy" and an average target price of $26.50.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently bought and sold shares of OMDA. Quarry LP purchased a new position in Omada Health during the fourth quarter worth $29,000. Raymond James Financial Inc. purchased a new stake in shares of Omada Health in the second quarter worth approximately $32,000. Versant Capital Management Inc lifted its stake in shares of Omada Health by 319.3% during the 2nd quarter. Versant Capital Management Inc now owns 2,998 shares of the company's stock worth $66,000 after acquiring an additional 2,283 shares during the last quarter. Strs Ohio boosted its holdings in Omada Health by 151.0% during the 4th quarter. Strs Ohio now owns 4,267 shares of the company's stock valued at $67,000 after acquiring an additional 2,567 shares during the period. Finally, New York State Common Retirement Fund purchased a new position in Omada Health during the 4th quarter valued at $73,000.

Omada Health Company Profile

Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company's platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.

In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source